A phase II trial of gemcitabine plus cisplatin (GP) in patients with inoperable biliary tract cancer (BTC)
In: Journal of Clinical Oncology, Jg. 23 (2005-06-01), S. 4133-4133
Online
unknown
Zugriff:
4133 Background: BTC is an aggressive cancer with median survival time rarely exceeding 6 months. While most BTC is unresectable, there is currently no standard systemic chemotherapy. Recently, pha...
Titel: |
A phase II trial of gemcitabine plus cisplatin (GP) in patients with inoperable biliary tract cancer (BTC)
|
---|---|
Autor/in / Beteiligte Person: | Lim, H. Y. ; Myung Ah Lee ; Tae Yong Kim ; Kim, Hoon-Kyo ; Park, J. O. ; Lee, Nam-Su ; Kang, Wonyoung ; Ahn, Myung-Ju ; Kim, Juyeon ; Byung Joo Park |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 23 (2005-06-01), S. 4133-4133 |
Veröffentlichung: | American Society of Clinical Oncology (ASCO), 2005 |
Medientyp: | unknown |
ISSN: | 1527-7755 (print) ; 0732-183X (print) |
DOI: | 10.1200/jco.2005.23.16_suppl.4133 |
Schlagwort: |
|
Sonstiges: |
|